In vitro enhancement of anticancer activity of paclitaxel by a Cremophor free cyclodextrin-based nanosponge formulation
Journal of Inclusion Phenomena and Macrocyclic Chemistry, ISSN: 0923-0750, Vol: 74, Issue: 1-4, Page: 201-210
2012
- 96Citations
- 81Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
A severe limitation for cancer therapy is the poor water solubility of many important therapeutic anticancer drugs. The development of novel delivery systems is therefore currently ongoing. We propose the use of β-cyclodextrin based nanosponges to deliver paclitaxel as an alternative to classical formulation in Cremophor EL. They are solid nanoparticles with mean diameter lower than 500 nm and spherical shape. Nanosponges show a safe profile being non-hemolytic and non cytotoxic. Nanosponges dissolved and encapsulated paclitaxel up to 2 mg/ml. The paclitaxel-loaded nanosponges formed a water stable colloidal system avoiding the recrystallization of paclitaxel. The in vitro release studies showed an almost complete release in 2 h without initial burst effect. Our study demonstrates that delivery of paclitaxel via nanosponges increased the amount of paclitaxel entering cancer cells and lowers paclitaxel IC50, therefore enhancing its pharmacological effect. β-Cyclodextrin based nanosponges can therefore be considered an alternative system to solubilize and deliver the paclitaxel. © 2012 Springer Science+Business Media B.V.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84864438172&origin=inward; http://dx.doi.org/10.1007/s10847-011-0101-9; http://link.springer.com/10.1007/s10847-011-0101-9; http://link.springer.com/content/pdf/10.1007/s10847-011-0101-9; http://link.springer.com/content/pdf/10.1007/s10847-011-0101-9.pdf; http://link.springer.com/article/10.1007/s10847-011-0101-9/fulltext.html; http://www.springerlink.com/index/10.1007/s10847-011-0101-9; http://www.springerlink.com/index/pdf/10.1007/s10847-011-0101-9; https://dx.doi.org/10.1007/s10847-011-0101-9; https://link.springer.com/article/10.1007/s10847-011-0101-9
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know